![David MacNaughtan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David MacNaughtan
Corporate Officer/Principal at
Sagard Holdings ULC
Profile
Mr. David MacNaughtan is a Partner & Head of Sagard Royalty Partners at Sagard Healthcare Royalties and a Partner at Sagard Holdings ULC.
Mr. MacNaughtan was previously employed as a Senior Principal by Canada Pension Plan Investment Board Private Investments, a Vice President-Business Development by Paladin Labs, Inc., an Investment Manager by Royal Bank Capital Corp., and an Executive VP & Co-Head-Royalty Monetization Fund by DRI Healthcare.
He also served on the board at Jaguar Health, Inc. and Isotechnika Pharma, Inc. He received his undergraduate degree from Queen's University, a graduate degree from Queen's University and an MBA from Rotman School of Management.
David MacNaughtan active positions
| Companies | Position | Start |
|---|---|---|
Sagard Holdings ULC
 Sagard Holdings ULC Investment ManagersFinance Provides alternative asset management services | Corporate Officer/Principal | 01/12/2018 |
Sagard Healthcare Royalties
 Sagard Healthcare Royalties Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01/01/2019 |
Former positions of David MacNaughtan
| Companies | Position | End |
|---|---|---|
| JAGUAR HEALTH, INC. | Director/Board Member | 21/02/2020 |
Canada Pension Plan Investment Board Private Investments
 Canada Pension Plan Investment Board Private Investments Investment ManagersFinance CPPIB Private Investments invests in companies located across the globe primarily in North America, Europe and Asia. The firm targets companies operating in the fields of technology, healthcare, industrials and service sectors. It provides financing for buyout, secondary and growth stage capital requirements with an investment size of USD 25 - 300 million. It acquires minority interest and also makes co-investments. | Private Equity Investor | 30/04/2018 |
| PALADIN LABS INC. | Corporate Officer/Principal | 01/09/2002 |
Royal Bank Capital Corp. | Corporate Officer/Principal | 01/08/1999 |
DRI Healthcare
 DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Corporate Officer/Principal | - |
Education of David MacNaughtan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
80
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
DRI Healthcare
DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Finance |
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceuticals | Health Technology |
Rotman School of Management
 Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canada Pension Plan Investment Board Private Investments
Canada Pension Plan Investment Board Private Investments Investment ManagersFinance CPPIB Private Investments invests in companies located across the globe primarily in North America, Europe and Asia. The firm targets companies operating in the fields of technology, healthcare, industrials and service sectors. It provides financing for buyout, secondary and growth stage capital requirements with an investment size of USD 25 - 300 million. It acquires minority interest and also makes co-investments. | Finance |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Royal Bank Capital Corp. | |
Jaguar Health, Inc.
 Jaguar Health, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sagard Holdings ULC
Sagard Holdings ULC Investment ManagersFinance Provides alternative asset management services | Finance |
Sagard Healthcare Royalties
Sagard Healthcare Royalties Investment ManagersFinance Functions as an alternative investment manager | Finance |
- Stock Market
- Insiders
- David MacNaughtan
